Clinical trials
Observational Hemolysis trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
8 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2013 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 3 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Boston Children's Hospital | 1 |
| National Human Genome Research Institute (NHGRI) | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| St. Jude Children's Research Hospital | 1 |
| State University of New York - Upstate Medical University | 1 |
| University Hospitals Cleveland Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hemolysis | 8 |
| Anemia | 2 |
| Anemia, Sickle Cell | 2 |
| Anemia, Hemolytic | 1 |
| Charcot-Marie-Tooth Disease | 1 |
| Dihydropyrimidine Dehydrogenase Deficiency | 1 |
| Erythroblastosis, Fetal | 1 |
| Hemoglobinopathies | 1 |
| Hemoglobinuria, Paroxysmal | 1 |
| Hyper-IgM Immunodeficiency Syndrome | 1 |
Trials
Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.